Nicotinell Icemint 2 mg

Nicotinell is a global brand of nicotine replacement therapy (NRT) products. It was originally developed by the Swiss pharmaceutical company Ciba-Geigy (later Novartis). The production of Nicotinell medicated chewing gum is primarily carried out in specialized facilities in Switzerland.

Following a joint venture in 2015 and a subsequent spin-off in 2022, the brand is now owned by Haleon, a leading global consumer healthcare company. Haleon was formed by combining the consumer health businesses of GSK and Pfizer before becoming an independent entity. The brand continues to be a staple in smoking cessation programs across Europe and North America.